Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Liver Carcinoma”

119 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 119 results

Early research (Phase 1)Study completedNCT04811898
What this trial is testing

A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment

Who this might be right for
Multiple Myeloma, RefractoryHepatocarcinomaAdvanced Solid Tumor
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro 17
Large-scale testing (Phase 3)Looking for participantsNCT05608213
What this trial is testing

Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 187
Early research (Phase 1)Study completedNCT02143401
What this trial is testing

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
CirrhosisHepatitis B InfectionHepatitis C Infection+6 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Study completedNCT00107861
What this trial is testing

Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases

Who this might be right for
Colorectal CarcinomaMetastases
Biogen 44
Testing effectiveness (Phase 2)Looking for participantsNCT04803318
What this trial is testing

Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultHepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 100
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Testing effectiveness (Phase 2)Study completedNCT02940496
What this trial is testing

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatitis C Infection+8 more
M.D. Anderson Cancer Center 15
Not applicableStudy completedNCT03146234
What this trial is testing

CAR-GPC3 T Cells in Patients With Refractory Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
RenJi Hospital 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Early research (Phase 1)Study completedNCT02595866
What this trial is testing

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Who this might be right for
AIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more
National Cancer Institute (NCI) 58
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableUnknownNCT04773769
What this trial is testing

Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas

Who this might be right for
Gastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal JunctionHepatocellular Carcinoma+3 more
Auxilio Mutuo Cancer Center 54
Early research (Phase 1)Active Not RecruitingNCT06757881
What this trial is testing

IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma

Who this might be right for
HCC
Shanghai Zhongshan Hospital 3
Early research (Phase 1)Study completedNCT00608361
What this trial is testing

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Looking for participantsNCT07639138
What this trial is testing

Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shunda Du 32
Early research (Phase 1)UnknownNCT04550663
What this trial is testing

NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors

Who this might be right for
Solid TumorHepatocellular CarcinomaColorectal Cancer+1 more
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 10
Testing effectiveness (Phase 2)Study completedNCT04511455
What this trial is testing

Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line Treatment

Who this might be right for
Hepatocellular Carcinoma Non-resectableMetastatic Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 22
Early research (Phase 1)Looking for participantsNCT06873659
What this trial is testing

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorGastric CancerLiver Cancer
Qurgen Inc. 96
Testing effectiveness (Phase 2)WithdrawnNCT01859182
What this trial is testing

Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the GallbladderAdenocarcinoma With Squamous Metaplasia of the GallbladderAdult Primary Cholangiocellular Carcinoma+12 more
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06910657
What this trial is testing

IDOV-Immune for Advanced Solid Tumors

Who this might be right for
Colorectal CancerPancreatic CancerMelanoma+13 more
ViroMissile, Inc. 78
Next Page